KAYE RANDALL (CMO) made both purchases and sales at LONGBOARD PHARMACEUTICALS, INC.
Purchased 100.00 shares and sold 48.3% of their position (16.77K shares) — review individual transaction dates and prices for directional context.
Common Stock
Shares
+100.00
Price / share
$24.82
Trade value
$2.48K
% of position
Common Stock
Shares
−100.00
Price / share
$20.87
Trade value
$2.09K
% of position
Common Stock
Shares
+16.67K
Price / share
$4.35
Trade value
$72.50K
% of position
Common Stock
Shares
−10.48K
Price / share
$34.55
Trade value
$361.95K
% of position
Common Stock
Shares
−6.19K
Price / share
$35.03
Trade value
$216.86K
% of position
Net shares
+0.00
Net value
-$505.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/23/2024 | P · Purchase | +100.00 | $24.82 | $2.48K | New position | 0.00 | 100.00 |
| Common Stock Indirect | 6/25/2024 | S · Sale | −100.00 | $20.87 | $2.09K | New position | 100.00 | 0.00 |
| Common Stock Direct | 8/12/2024 | M · Option Exercise | +16.67K | $4.35 | $72.50K | 93.0% | 17.92K | 34.59K |
| Common Stock Direct | 8/12/2024 | S · Sale | −10.48K | $34.55 | $361.95K | 30.3% | 34.59K | 24.11K |
| Common Stock Direct | 8/12/2024 | S · Sale | −6.19K | $35.03 | $216.86K | 25.7% | 24.11K | 17.92K |
| Total | +0.00 | -$505.91K | ||||||
Stock Option (Right to Buy)
Common Stock
16.67K shares
Shares
−16.67K
Strike price
4.35
Held after
129.63K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock16.67K shares | 8/12/2024 | M · Option Exercise | −16.67K | 4.35 | — | 129.63K |
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 17.92K | Direct |
| Total | 17.92K | 17.92K direct |